Role of neutrophils in cutaneous leishmaniasis
AbstractNeutrophils are always present in the cytomorphologic process of leishmaniasis but their role is still not fully understood. Microscopic examination was done on smears from 56 cases of clinically diagnosed cutaneous leishmaniasis. Neutrophils were the predominant cells in the smear [>35% of the total cell count including neutrophils, macrophages and lymphocytes] in 7% of cases, a minority [10%-35% of total cells] in 36% of cases and rare [< 10% of total cells] in 57% of cases. Microscope images confirmed that neutrophils appeared to have an important role in leishmania elimination through phagocytosis of amastigotes in the later stages of the disease process
Daboul, M.W. (2010). Role of neutrophils in cutaneous leishmaniasis. EMHJ - Eastern Mediterranean Health Journal, 16 (10), 1055-1058, 2010 http://www.who.int/iris/handle/10665/118003
JournalEMHJ - Eastern Mediterranean Health Journal, 16 (10), 1055-1058, 2010
MetadataShow full item record
Showing items related by title and MeSH subject.
Control of cutaneous leishmaniasis in Afghanistan: achievements and challenges – Lutte contre la leishmaniose cutanée en Afghanistan: progrès accomplis et défis à relever World Health Organization = Organisation mondiale de la Santé (2018-04-27)
Cutaneous leishmaniasis: control in selected countries of the WHO Eastern Mediterranean and African Regions: report of an interregional network meeting, Casablanca, Morocco, 23–24 June 2014 World Health Organization (WHO/HTM/NTD/IDM/2015.4, 2015)
Effectiveness of meglumine antimoniate against L.tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran Karamian, M.; Faroghi Bojd, M.S.; Salehabadi, A.; Hemmati, M.; Barati, D.A. (2015)With limited options to treat cutaneous leishmaniasis, constant monitoring of the rate of resistance to pentavalent antimony-based drugs is needed. This study identified the infecting Leishmania species and evaluated the results of meglumine antimoniate (Glucantime®) therapy in a new focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran. Smears from 150 patients showed that 141 patients were infected by L. tropica and 9 by L. major. In total, 141 patients with L. tropica infection completed Glucantime® treatment and ...